- Industry Solutions
Industry Solutions
For more than 25 years, Model N has been the leader in end-to-end commercialization, revenue optimization, and compliance for pharmaceutical and medtech innovators.
- Right block
Contact Us
Case Study
Whitepaper
Pharma manufacturers face the problem of paying unauthorized rebates to third-party payers for prescriptions bought at a 340B discount.
Companies are increasingly challenged with automating and paying multi-tier channels and indirect partners
- No simple linkage between sales and dispensing transactions means companies cannot easily determine if stock was acquired at 340B prices.
- As part of rebate contracts, payers submit transactions that were dispensed by pharmacies using product acquired at 340B prices.
- With heavy discounting and penny pricing, manufacturers may pay more in discounts than the drug’s original price, albeit to multiple entities.
The benefits of Model N 340B Vigilance
Model N 340B Vigilance helps reduce the problem of duplicate discounts.
Optimize revenue
Reduce revenue loss caused by duplicate discounts between 340B and payer and/or Medicaid claims.
Ensure compliance
Continuously monitor compliance with the 340B Drug Pricing Program.
Gain insights
Gain insights and control over 340B discounts and policy.
Product Features
Third-party integrations
Integrated with leading 340B vendors to identify duplicate discount script transactions.
Definitive transaction data submissions
Covered entities are notified of any instances of duplicate Medicaid rebates and given the opportunity to correct actions and improve 340B program integrity.
Enhanced checks and reporting
Expands the validation capabilities already performed within Validata, enabling more accurate identification of ineligible rebate claims.
Related Products
Related Resources
340B Vigilance Case Study
Pharma manufacturer uses 340B Vigilance to prevent duplicate discounts VIEW Case Study
Best Practices for Complying with 340B
Read this white paper to learn how you can improve the chargeback process, generate an audit trail, and ensure correct 340B pricing. VIEW Whitepaper
